TTIP must not jeopardize EU safeguards, say MEPs
This article was originally published in Scrip
The Transatlantic Trade and Investment Partnership (TTIP) could lead to common standards in areas like the safety of medicines and medical devices, but it must not "sacrifice certain European safeguards on the altar of free trade", an influential European Parliament committee has said.
You may also be interested in...
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including researching new uses of existing products and clinical trials of new vaccines.
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
AMD patients in the UK can legitimately be given compounded bevacizumab (Roche’s Avastin) after the appeals court said NHS trusts could offer a drug off-label for economic reasons where there were no safety or efficacy concerns.